CJC-1295 with DAC
A GHRH analog with a “drug affinity complex” that binds albumin, stretching its action from minutes to about a week.
Investigational (development stopped); not approved.
Used for
- Raising GH and IGF-1 with one injection a week
How it works
Keeps GHRH receptors stimulated continuously; GH still comes in pulses, but the baseline rises and IGF-1 stays up for days.
Half-life: 5.8–8.1 days (Teichman 2006)
What the research shows
- In healthy adults, single doses raised GH 2–10× for 6+ days and IGF-1 for 9–11 days; half-life 5.8–8.1 days.
- With repeated doses IGF-1 stayed above baseline for up to 28 days; no serious reactions at 30–60 mcg/kg.
- Its developer stopped work on it in the mid-2000s; there is no approved use.
Dosing
Dosing isn’t listed on the public site. In the app, each published option is shown with its source (a drug label, a clinical guideline, a trial or community reports) and can be turned into a protocol you review.
Work out the units to draw for your vial →Side effects
- Flushing, injection-site redness
- Water retention, joint aches, numb or tingling hands
Cautions
- Raises GH and IGF-1. Avoid with active cancer or a history of it; can raise blood sugar. Check IGF-1 and fasting glucose on bloodwork.
- The constant signal (“GH bleed”) differs from natural pulses; long-term effects are unknown.
- Prohibited in tested sports (WADA).
- Research-chemical vials have no quality control: purity, dose and sterility vary. Third-party testing helps but is no guarantee.
Storage
Unmixed powder: freezer or fridge, away from light.
Once mixed with bacteriostatic water: fridge; the common rule is to use it within 28 days.
There is no label or published stability data for this one, so treat these as habits, not limits.
More in Growth hormone
Reference only, not medical advice. Written for this app from the cited research. Doses marked community-reported are not from trials.